Year: 2019

No Picture
Trading Ideas

UAW cites 'significant progress' in Ford talks as GM strike continues

October 3, 2019 admin Comments Off on UAW cites 'significant progress' in Ford talks as GM strike continues

The United Auto Workers union said on Thursday it has made “significant progress” in contract talks with Ford Motor Co , even as a strike at General Motors Co is in its third week. The UAW agreed to extend contracts with Ford and Fiat Chrysler Automobiles NV as it focused first on GM. About 48,000 UAW members at GM went on strike on Sept. 16 seeking higher pay, greater job security, a bigger share of the leading U.S. automakers profit and protection of healthcare benefits. …read more […]

No Picture
Trading Ideas

Best Fast-Food Stocks for Profiting on the Munchies

October 3, 2019 admin Comments Off on Best Fast-Food Stocks for Profiting on the Munchies

Cannabis is facing a number of headwinds at the moment.
There’s the ongoing vaping crisis…
The glacial pace of mergers and acquisitions being greenlit by regulators…
And a whole host of other missteps by companies in Canada and the U.S.
For pot stock investors, it’s been a maelstrom of negative headlines. And all of this has helped trigger the longest bear market in the industry’s nascent history.
That’s why, today, I want to offer another way investors can tap into marijuana’s explosive growth… but with some added safety.
In fact, it’s a way to play marijuana legalization without actually owning any pot stocks.
New data shows that …read more […]

No Picture
Trading Ideas

UPDATE 1-Canada's Fortune Minerals scales back mine on weak cobalt prices

October 3, 2019 admin Comments Off on UPDATE 1-Canada's Fortune Minerals scales back mine on weak cobalt prices

Canada’s Fortune Minerals Ltd said on Thursday it would shelve plans to upsize its early-stage cobalt mine in the country’s far north while it continues to hunt for a strategic partner. The company’s decision to scale back plans at its proposed Nico development in Canada’s Northwest Territories comes after cobalt prices, hit by oversupply, have fallen from $47,000 per tonne in January to around $35,470. London, Ontario-based Fortune Minerals said current prices do not justify expanding the daily mill production rate to 6,000 tonnes from 4,650 tonnes at its proposed Nico project, which would also produce gold and …read more […]

No Picture
Trading Ideas

Tesla sets delivery record, falls short of expectations

October 3, 2019 admin Comments Off on Tesla sets delivery record, falls short of expectations

Shares of Tesla are sliding Thursday after record deliveries in the third quarter fell short of investors’ expectations. Despite delivering a record 97,000 vehicles globally, it fell short of CEO Elon Musk’s goal of 100,000. Yahoo FInance’s Adam Shapiro, Julie Hyman, Pras Subramanian and Dan Roberts discuss with Invesco Chief Global Market Strategist Kristina Hooper. …read more […]

Healthcare

CytoDyn (OTC: CYDY) Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH

October 3, 2019 admin Comments Off on CytoDyn (OTC: CYDY) Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH

VANCOUVER, Washington, Oct. 01, 2019– CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today FDA clearance […]

Healthcare

CytoDyn (OTC: CYDY) Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients with Treatment-Naive, Metastatic Triple-Negative Breast Cancer

October 3, 2019 admin Comments Off on CytoDyn (OTC: CYDY) Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients with Treatment-Naive, Metastatic Triple-Negative Breast Cancer

VANCOUVER, Washington, Sept. 27, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications announced today the […]

Newsmakers

Medicine Man Technologies (OTC: MDCL) Resoundingly Applauds the Historical Passing of the SAFE Banking Act by the U.S. House of Representatives

October 3, 2019 admin Comments Off on Medicine Man Technologies (OTC: MDCL) Resoundingly Applauds the Historical Passing of the SAFE Banking Act by the U.S. House of Representatives

– SAFE Banking Act would provide cannabis companies access to banking services that all other legal businesses have- American cannabis companies would be on more equal footing with Canadian cannabis peers with access to depository […]